A detailed history of Pnc Financial Services Group, Inc. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 24,005 shares of BMEA stock, worth $89,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,005
Previous 21,000 14.31%
Holding current value
$89,538
Previous $212,000 56.13%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$3.88 - $12.41 $11,659 - $37,292
3,005 Added 14.31%
24,005 $93,000
Q2 2024

Aug 09, 2024

BUY
$4.14 - $15.3 $53,786 - $198,777
12,992 Added 162.24%
21,000 $94,000
Q1 2024

May 10, 2024

BUY
$13.92 - $19.5 $111 - $156
8 Added 0.1%
8,008 $119,000
Q4 2023

Feb 09, 2024

BUY
$8.37 - $19.8 $66,960 - $158,400
8,000 New
8,000 $116,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $109M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.